drugset / Trial / NCT07126873
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NaSequentialOpen-labelTreatment
Summary
This study will evaluate the safety, tolerability and efficacy of E-islet 01 in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia
Timeline
- Start
- 2025-08-11
- Primary completion
- 2027-12-31
- Completion
- 2029-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E-islet 01 | Cell therapy | — | Other |